Investing in NeuroPace Inc (NPCE) Is Getting More Attractive

NUE

NeuroPace Inc’s recently made public that its 10% Owner ORBIMED ADVISORS LLC unloaded Company’s shares for reported $2.67 million on May 14 ’25. In the deal valued at $15.85 per share,168,136 shares were sold. As a result of this transaction, ORBIMED ADVISORS LLC now holds 3,238,199 shares worth roughly $34.23 million.

Then, Morrell Martha sold 78,334 shares, generating $1,074,844 in total proceeds. Upon selling the shares at $13.72, the CHIEF MEDICAL OFFICER now owns 81,993 shares.

Before that, KCK LTD. sold 5,270,845 shares. NeuroPace Inc shares valued at $49,545,943 were divested by the 10% Owner at a price of $9.40 per share. As a result of the transaction, KCK LTD. now holds 0 shares, worth roughly $0.0.

H.C. Wainwright initiated its NeuroPace Inc [NPCE] rating to a Buy in a research note published on May 28, 2025; the price target was $18. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. Wells Fargo also remained covering NPCE and has increased its forecast on March 14, 2024 with a “an Overweight” recommendation from previously “an Equal weight” rating. Leerink Partners started covering the stock on January 30, 2024. It rated NPCE as “an Outperform”.

Price Performance Review of NPCE

On Monday, NeuroPace Inc [NASDAQ:NPCE] saw its stock jump 1.54%% to $10.57. Over the last five days, the stock has lost -4.52%. NeuroPace Inc shares have risen nearly 62.62% since the year began. Nevertheless, the stocks have fallen -5.54% over the past one year. While a 52-week high of $18.98 was reached on 05/21/25, a 52-week low of $5.45 was recorded on 03/11/25.

Levels Of Support And Resistance For NPCE Stock

The 24-hour chart illustrates a support level at 10.07, which if violated will result in even more drops to 9.58. On the upside, there is a resistance level at 10.83. A further resistance level may holdings at 11.10.

How much short interest is there in NeuroPace Inc?

A steep rise in short interest was recorded in NeuroPace Inc stocks on 2025-05-30, dropping by 37895.0 shares to a total of 0.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 0.39 million shares. There was a decline of -10.65%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on November 10, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $11 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.